Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009. (Q30224646)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009. |
scientific article |
Statements
1 reference
Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009. (English)
1 reference
Karen L Kotloff
1 reference
Kathryn M Edwards
1 reference
Lisa A Jackson
1 reference
Diana L Noah
1 reference
Wilbur H Chen
1 reference
Emmanuel B Walter
1 reference
Mark Wolff
1 reference
Pandemic H1N1 Vaccine Adult Study Group
1 reference
23 April 2012
1 reference
1 reference
4240-4248
1 reference
Identifiers
1 reference
1 reference
1 reference